Continuous-Blood Glucose Monitoring Market Size worth US$ 10.25 billion by 2030 to grow at a CAGR of 9.90% | Growth Plus Reports

Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Continuous-Blood Glucose Monitoring Market will clock US$ 10.25 billion by 2030. The rapidly increasing adoption of digitalization due to growing urbanization is a major driver for the Continuous-Blood Glucose Monitoring Market. This exclusive information is published by Growth Plus Reports in its report titled "Continuous-Blood Glucose Monitoring Market – Global Outlook & Forecast 2022-2030

Download Sample PDF Brochure of Continuous-Blood Glucose Monitoring Market:

https://growthplusreports.com/inquiry/request-sample/continuous-blood-glucose-monitoring-market/7990

Market Driver

Technological advancements in CGMS (Continuous Glucose Monitoring System) is the major factor that will increase the global market for continuous blood glucose monitoring in the upcoming years. Technological advancements in continuous monitoring systems have resulted in the approval of many high-tech products. Additionally, a lot of industry participants have expressed interest in creating non-piercing devices. For instance, the Apple Watch Series 7 tests blood glucose levels using a non-invasive optical sensor. Similar to this, Florida-based startup Alertgy is developing a noninvasive CGM system known as ANICGM. The organistation is using MRI-like miniaturised technologies on a bracelet, which monitors glucose readings.

Excerpts from ‘by Component'

Sensors, integrated insulin pumps, and transmitters & receivers are the segments under component type. The market has been controlled by the sensor divisions. The devices use sensors to measure the patients' blood glucose levels. A continuous glucose monitor (CGM) gadget searches the interstitial fluid for glucose using a filament coated in glucose detecting enzymes (the fluid between the cells). Biological recognition components, a transducer that converts this recognition into a signal, and a processing system that converts the signal into readable form are the three fundamental components of a glucose biosensor. The majority of glucose measurements are based on how glucose oxidase interacts with the body. The sensor is connected to the transmitter, which is compact and lightweight. The transmitter wirelessly transmits glucose data from the sensor to an insulin pump to the monitor, depending on whether the sensor is connected to a pump. The receiver, a discreet, portable device that displays the glucose data sent from the transmitter, is carried by the user. This device simultaneously displays the current glucose level and trended data. The receiver also notifies the user of impending emergencies. Many CGMs can transmit glucose information directly to an insulin pump.

Excerpts from ‘by End User'

The continuous glucose monitoring market is divided into three categories based on the end user:

• Diagnostic Facilities
• Hospitals
• Homecare Services

The global market has been dominated by the homecare sector. Patients and physician can benefit from valuable information provided by home blood pressure devices and glucose monitoring for controlling diabetes mellitus and hypertension at the comfort of their homes without the need to go to the physician's office.

Excerpts from ‘by Region'

The global market for continuous blood glucose monitoring has been divided into four regions based on geography:

• North America
• Europe
• Asia Pacific
• The Rest of The World

The market has been dominated by the region of North America. The presence of several market participants and high reimbursement programmes, such as the Dexcom Patient Assistance Program, Abbott Diabetes Care Patient Assistance Program, and Medtronic Diabetes Patient Relief Programs, are factors influencing the market's growth. A large senior population with diabetes dominates the European market for continuous blood glucose monitoring. This age group requires specific care, which can be delivered by cutting-edge solutions. Because of the region's large patient population, increasing need for monitoring systems, and emerging nations with higher healthcare standards, the Asia Pacific region is expected to have a growing market for continuous blood glucose monitoring during the course of the forecast period.

Excerpts from ‘Competitive Landscape'

Some of the prominent players operating in the continuous blood glucose monitoring market are

• Abbott Laboratories
• Dexcom Inc.
• Echo Therapeutics Inc.
• Glysens Incorporated.
• Insulet Corporation
• F. Hoffman -La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novo Nordisk A/S
• Medtronics Plc
• Senseonics Holdings Inc. And Among Other

Inquire Before Buying This Research Report:

https://growthplusreports.com/inquiry/before-buying/continuous-blood-glucose-monitoring-market/7990

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1.    Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2021) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET - ANALYSIS & FORECAST, BY COMPONENT
   1. Sensors
   2. Transmitters & Receivers
   3. Integrated Insulin Pumps
6. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET - ANALYSIS & FORECAST, BY END USER
   1. Diagnostic Centers
   2. Hospitals
   3. Homecare services

TOC Continue…

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pipeline Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Quickly Purchase Premium Copy of Continuous-Blood Glucose Monitoring Market Report:

 https://growthplusreports.com/checkout?_token=G2Qb83YVVkLLcL7Mjvq8AiXw8ciW9V4DapBAsazQ&report_id=7990&license=Single

About Us        

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

 Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/